We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Itās a pitty they have a small holding in Kannabo. That stock could be a winner next year.
Theyāre going to have to issue a RNS about the rise, either that or a speeding ticket.
And that was before they bought out the GP Service, with access to NHS patient records and over 4000 pharmacies.
Also, research Ian Mattioli, our new Chair, he bought Ā£500Kās worth of stock and owns his own, highly respected Wealth management Company. Itās listed.
For a massive re rate when you consider they were in the 40's
This will be top of the risers board here soon then that will be interesting to see how high this goes today, Something very interesting happening in this sector for sure.
In the first 30 mins this morning.
Market closes at 12:30 today, could be quite a rush to get in here before markets re-open in the New Year.
2024 will be the year for KNB.
Correction - chill has pretty much quadrupled revenue in the second half of the year whilst reducing operating costs.
I believe KNB is on chills website if I am not wrong.
Crazy increase for one day. Lot of us might of got it right saying that was the bottom.
Chill is also up significantly today. Maybe to do with the cannabis sector in general. Definitely an improvement on volume from recent months.
Hopefully this continues tomorrow too. Iām expecting a big year in 24. So many positive RNS since IPO and CE mark will be a big step forward.
GP service and treat it both good revenue streams too. Excited to see what Ian is going to do for the business. GLA. Really feel this will rocket when the time is right.
I need something I bought at 49p with 10k which is a lot of money to me
Interesting movement today, perhaps CE approval is now very close.
Agreed that this is currently very undervalued given the traction that it now has.
You bought shares in the best medical cannabis company in the UK, give yourself a pat on the back.
Absolute rubbishā¦.. scammersā¦.
Other than dilution, I agree I canāt see this going much lower. Think we may see more dilution first but could be a great time to buy after. Change in legislation, CE approval or significant revenue increases could really accelerate this company. With momentum, I think we could see this with a Ā£50m+ MCAP easily. Just hope all the silence is leading to something promising.
When you look at the Fundamentals and finances of Kanabo, there is no reason for the SP to be so low. Very undervalued, and I expect very soon to see this rise.
Holding Firmly.
Taken from half year results- Medical inhaler completes all necessary stages for CE Mark, certification pending - Our distinctive medical device inhaler has successfully completed all necessary stages to become the first of its kind to achieve CE mark certification. We anticipate formal certification to be awarded in the coming month
EU product expansion - pending receipt of CE mark for our VapePod MD medical device inhaler, build on our UK footprint and expand our distributor network outside of the UK across Europe to launch into appropriate new territories, expanding our footprint and driving geographic diversification.
https://businessofcannabis.com/delayed-again-frustration-as-spd-prevents-germanys-cannabis-bill-from-progressing-at-11th-hour/
When Germany sort themselves out this will be a big market for the CE marked medical vape, an essential requirement in any medical grade device. So next year for the German market and hopefully we will see some change in the UK, maybe Richie will want to give everone the feel good factor and announce cannabis products on prescrrition through the NHS, got to be a vote winner and help him gain some popularity prior to the GE.
The CE pending talk has been going on since the company floated on the market, progress is mentioned in the September half year update that weāre only a few months away from getting the CE certificationā¦ anyone heard/seen anything about this recently? We had a big share price boost last Dec/Jan off the back of it being expected (4p per share) but the delays are probably causing some concerns which is why weāre sitting so low at the momentā¦ although I have no understanding of what timeframe it takes to gain a certification
Government policies is what is holding this company back, once the laws change thatās when people will sit up and take notice. Until that happens growth will be slow.
This stock is hugely undervalued. When the market realises this the SP should re-rate.
It looks like she has opted out on making any decisions where there is a conflict of interest with her husbands business and it wouldn't be a justifiable reason to deny people access to the funding so hopefully that was taken into consideration before she was appointed.
https://inews.co.uk/news/new-health-secretary-husbands-business-2753869
Only problem is the new secretary of health Victoria Atkins has recused herself from any decision making regarding cannabis because of her husband is ABF sugar , largest producers of medical cannabis in the UK.
The Chancellor is being urged to bring forward special fund for medical cannabis in his Autumn statement and i like the response from Penny Mordaunt.
Ms Mordaunt added: āI will immediately after this session ā¦ contact the Department of Health, will contact through my PPS (parliamentary private secretary), the Secretary of State for Health and make her aware of this situation.
āWe appreciate that we cannot make clinical decisions on behalf of individual patients.
āBut what we can ensure is that if a drug or medical device could benefit a patient that the systems are in place to ensure that they get access to it ā even if it is not a Nice (National Institute for Health and Care Excellence) approved treatment, people in this country still have that right.
āWe will facilitate an immediate meeting with the Department of Health and I will be kept informed of progress on this matter.ā
https://www.independent.co.uk/news/uk/natalie-elphicke-penny-mordaunt-chancellor-nhs-jeremy-hunt-b2448476.html
Arms999
I got out with a loss in the hundreds when it was in the 26ās and meant to get back in when it or if it fell a bit more. I then forgot all about it and only looked back in when it had dropped to
10pish.
Didnāt fancy after that and Iāve been very lucky to dodge this bullet. We've all had a share where this has happened though. Best we can do is learn from it and move on. Not saying sell up, itās entirely your decision what you do, obviously.
Good news as the company are looking to expand the access to Treat It digital consultation service through UK pharmacies then securing this contract extension looks to be a very important step and as mentioned in their Half Year Results as stated below.
Partnership with UK high street pharmacies - undertake a pilot programme that will see Kanabo collaborate with physical high street pharmacies to trial in-pharmacy consultations via our Treat It clinic, tapping into the pharmacies' existing patient networks to broaden Kanabo's outreach and addressable market.
I'm 10k in.at 49p I need a miracle on the sp